WealthCollab’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.9K Buy
912
+605
+197% +$12K 0.01% 429
2025
Q4
$6.03K Buy
307
+197
+179% +$4.09K ﹤0.01% 680
2025
Q3
$3.03K Sell
110
-57
-34% -$1.75K ﹤0.01% 769
2025
Q2
$5.1K Sell
167
-285
-63% -$8.09K ﹤0.01% 634
2025
Q1
$12.2K Buy
452
+373
+472% +$11.8K 0.01% 421
2024
Q4
$2.84K Buy
79
+40
+103% +$1.5K ﹤0.01% 694
2024
Q3
$1.48K Sell
39
-393
-91% -$16.1K ﹤0.01% 809
2024
Q2
$19.5K Sell
432
-65
-13% -$2.99K 0.01% 291
2024
Q1
$24.1K Buy
497
+28
+6% +$1.37K 0.02% 270
2023
Q4
$25.1K Buy
+469
New +$23.7K 0.02% 234

Other funds holding USNA

WealthCollab's USNA Position: Q1 2026 in Review

WealthCollab increased its Usana Health Sciences (USNA) stake by 197% in Q1 2026, buying an estimated $12K and bringing the position to 912 shares worth $15.9K. The position accounts for 0.01% of the portfolio, ranked #429.

WealthCollab first reported a position in USNA in Q4 2023 and has held it in 10 quarters since. The position peaked at $25.1K in Q4 2023. 139 funds tracked by Wall St. Rank hold USNA as of Q1 2026.

  • WealthCollab held 912 shares of Usana Health Sciences worth $15.9K as of Q1 2026.
  • WealthCollab bought 605 Usana Health Sciences shares in Q1 2026, an estimated $12K.
  • Usana Health Sciences made up 0.01% of WealthCollab's portfolio in Q1 2026, its #429 holding.
  • WealthCollab first reported a position in Usana Health Sciences in Q4 2023 and has held it in 10 quarters since.
  • WealthCollab's Usana Health Sciences position peaked at $25.1K in Q4 2023.
  • 139 funds tracked by Wall St. Rank held Usana Health Sciences as of Q1 2026.

Based on WealthCollab's 13F filing for Q1 2026, filed 13 May 2026.